New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.

Celgene COO Scott Smith Precipitously Resigns

Celgene has had a rocky last couple of months, with its share price dropping from $146 to $87 since October last year. This time, the blame game seems to fall on Chief Operating Officer, Scott Smith. 

Brexit Threat to UK Genomics Industry

The UK’s position as a world leader within the global Genomics industry could be under threat thanks to uncertainties about the future working status of EU nationals in this country. 

Pharma Unit Overhaul for GSK

Pharmaceutical company GlaxoSmithKline is planning a commercial reboot to streamline their budget, potentially generating budget savings of 20%.